Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

PC-mAb for secondary prevention after myocardial infarction

Reference number
Coordinator Athera Biotechnologies AB
Funding from Vinnova SEK 69 000
Project duration August 2012 - September 2012
Status Completed

Last updated 25 November 2019

Reference number 2012-02888